Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)

Chemical name 3,4-methyl-2,5-dimethoxy-amphetamine or
Chemical formula C13H22NO2
Chemical structure of Ganesha

Ganesha, or 2,5-dimethoxy-3,4-dimethylamphetamine, is a lesser-known psychedelic drug. It is also a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage range is listed as 24-32 mg. Ganesha is sold in the form of dark red crystals. The drug is usually taken orally, although other routes such as rectally may also be used. Ganesha is synthesized from 2,5-dimethoxy-3,4-dimethylbenzaldehyde. Ganesha is the amphetamine analogue of 2C-G. It is a particularly long lasting drug, with the duration listed in PIHKAL as being 18 - 24 hours, which might make it undesirable to some users. It is named after the Hindu deity, Ganesha. Very little data is known about the dangers or toxicity of Ganesha. Effects of Ganesha include:

  • Strong closed-eye visuals
  • An increased appreciation of music
  • Powerful relaxation and tranquility

Homologues[edit | edit source]





3C-G-3[edit | edit source]

Dosage: 12-18 mgs

Duration: 8-12 hours

Effects: Enhancement of reading, no visuals or body load.

2C analog: 2C-G-3

3C-G-4[edit | edit source]

Dosage: unknown

Duration: unknown

Effects: unknown

2C analog: 2C-G-4

3C-G-5[edit | edit source]

Dosage: 14-20 mgs

Duration: 16-30 hours

2C analog: 2C-G-5

See also[edit | edit source]

External links[edit | edit source]

Categorization[edit | edit source]


This page uses Creative Commons Licensed content from Wikipedia (view authors).
Community content is available under CC-BY-SA unless otherwise noted.